Quantitative CT imaging and advanced visualization methods: potential application in novel coronavirus disease 2019 (COVID-19) pneumonia.
Prashant NagpalJunfeng GuoKyung Min ShinJae-Kwang LimKi Beom KimAlejandro P ComellasDavid W KaczkaSamuel PetersonChang Hyun LeeEirc A HoffmanPublished in: BJR open (2021)
Increasingly, quantitative lung computed tomography (qCT)-derived metrics are providing novel insights into chronic inflammatory lung diseases, including chronic obstructive pulmonary disease, asthma, interstitial lung disease, and more. Metrics related to parenchymal, airway, and vascular anatomy together with various measures associated with lung function including regional parenchymal mechanics, air trapping associated with functional small airways disease, and dual-energy derived measures of perfused blood volume are offering the ability to characterize disease phenotypes associated with the chronic inflammatory pulmonary diseases. With the emergence of COVID-19, together with its widely varying degrees of severity, its rapid progression in some cases, and the potential for lengthy post-COVID-19 morbidity, there is a new role in applying well-established qCT-based metrics. Based on the utility of qCT tools in other lung diseases, previously validated supervised classical machine learning methods, and emerging unsupervised machine learning and deep-learning approaches, we are now able to provide desperately needed insight into the acute and the chronic phases of this inflammatory lung disease. The potential areas in which qCT imaging can be beneficial include improved accuracy of diagnosis, identification of clinically distinct phenotypes, improvement of disease prognosis, stratification of care, and early objective evaluation of intervention response. There is also a potential role for qCT in evaluating an increasing population of post-COVID-19 lung parenchymal changes such as fibrosis. In this work, we discuss the basis of various lung qCT methods, using case-examples to highlight their potential application as a tool for the exploration and characterization of COVID-19, and offer scanning protocols to serve as templates for imaging the lung such that these established qCT analyses have the best chance at yielding the much needed new insights.
Keyphrases
- coronavirus disease
- machine learning
- lung function
- computed tomography
- sars cov
- chronic obstructive pulmonary disease
- high resolution
- dual energy
- interstitial lung disease
- deep learning
- cystic fibrosis
- respiratory syndrome coronavirus
- systemic sclerosis
- magnetic resonance imaging
- oxidative stress
- randomized controlled trial
- positron emission tomography
- air pollution
- pulmonary hypertension
- contrast enhanced
- liver failure
- image quality
- big data
- photodynamic therapy
- fluorescence imaging
- mass spectrometry
- magnetic resonance
- sensitive detection